Edinburgh EH8 9XD, UK
Mary Pickford was an experimental physiologist who carried out pioneering work on the actions of the hormones (oxytocin and vasopressin [syn. antidiuretic hormone, ADH]) secreted by the posterior pituitary gland, which is part of the brain. She provided understanding of how the secretion of these hormones is controlled to regulate body fluid composition, specifically the maintenance, through actions on the kidneys, of normal osmolarity and Na + concentration, and hence blood volume and pressure. Using the water-loaded dog model she showed that vasopressin is the only hormone that regulates the excretion of water, by stimulating the kidneys to concentrate urine; she found that oxytocin could stimulate excretion of Na + . She showed that acetylcholine is an excitatory neurotransmitter in the hypothalamus, stimulating the neurons that produce vasopressin to secrete-the first evidence for acetylcholine action in the brain. The principles that Mary established have been extensively confirmed; hence, she was important in the establishment of the concepts and discipline of neuroendocrinology, which is about the bidirectional interactions between hormones and the brain. Using human and animal models, in her later work Mary focused on possible roles of interactions between female sex hormones and vasodilating actions of oxytocin in the perimenopausal problem of 'hot flashes' (or 'hot flushes') experienced by many women. She faced, but overcame, entrenched gender prejudice during her career; she was the first woman to be elected to the Pharmacological Society, and the first woman appointed to a chair in the Edinburgh Medical School. In 1928 Mary presented research with Verney, using the Starling heart-lung preparation to study control of the renal circulation, at the thirteenth International Physiological Congress in Boston, USA (2) (see also Rall 2016) ; the eleventh Congress had been in Edinburgh in 1923. On this visit to the USA, she enjoyed being mistaken for the Canadian actress Mary Pickford; the liner on which she was travelling was met by a large squad of reporters who believed that it was the film actress who was on board. In the same year Mary was elected to membership of the Physiological Society. Nevertheless, it was difficult for her to get research work at that time; there were few women doctors and there was prejudice against women scientists. For a time she had to be content to teach the history of science.
In 1930, she registered as a medical student with the General Medical Council and for three years worked part-time in the Department of Pharmacology, and simultaneously studied clinical medicine, at University College Hospital, supported by a bequest of £2000 from her godmother. Mary achieved the LRCP, MRCS in 1933, and took up an appointment as house physician and casualty officer at Stafford General Infirmary. In the same year her name appeared on two significant papers with Verney, communicated to the Royal Society (3, 4) .
Mary continued with her scientific development, giving a communication to the Physiological Society in 1934 (5), and in 1935 she became the first female member of the Pharmacological Society. During this period Verney had bouts of illness, and Mary commented that during his absence she taught a subject that she had never learned, but managed to keep one chapter ahead of the next lecture! She acknowledged the help of Dr Raymond Ing (FRS 1951) and Lovatt Evans at this time.
In 1936, the year of publication of her first full paper on renal actions of posterior pituitary extract as sole author (6), she won a Beit Memorial Fellowship and moved to Cambridge to continue work with Verney. This culminated in her 1939 paper, which suggested that acetylcholine might be a central neurotransmitter and involved in the release of an antidiuretic substance produced by the pituitary gland (7).
Mary was appointed as a lecturer in physiology at the University of Edinburgh in 1939. Wartime reduced the possibility of research, and the teaching load was excessive because so many men were serving in the military; nevertheless, by 1945 she had written a paper for Physiological Review (8) .
During the Second World War Mary did locum work to relieve various general practitioners during her university vacations. While acting as a locum in Camberwell during the Blitz, she donned a tin hat and went in search of the wounded; her casualty experience in Stafford and her knowledge of physiology were put to full use. She also did locum work in Ross-on-Wye, which was crowded at that time, and helped in clinics at the Royal Hospital for Sick Children, Edinburgh. After the war, during the Christmas holiday of 1946, Mary flew by flying boat to Hong Kong to visit her brother, who had been interned in Shanghai during the war; she described this as a wonderful way of travelling.
Mary received her DSc from Edinburgh University in 1951, which was also the year in which her mother died. She was promoted to reader in physiology in 1952.
Research in the early years (pre-1958) Mary's promise as an outstanding research scientist is revealed in her first scientific paper, in 1927 (1). This pharmacological paper indicates great promise as it is elegantly written, based on an implicit hypothesis and reveals great care in performing experiments, identification of sources of error and intelligent and critical interpretation of the quantitative results in the context of theories at the time of drug actions and interactions at the cell surface. For this first paper Mary used both initials, L. M., but for most later papers she preferred to use just M. or Mary-emphasizing that this was the work of a woman.
Posterior pituitary hormones in water and salt balance

Control of water excretion by the antidiuretic hormone (ADH; syn. vasopressin)
With Verney, Mary gained expertise in using conscious dogs (following a tradition in physiological research from the late nineteenth century), tenderly cared for, to carry out experiments on the control of renal function: specifically using the excretion of a water-load by the kidney as a model to study how this is achieved, and also to use this model to test hypotheses about the role of the posterior pituitary gland in the formation of a concentrated urine by the kidney, thereby conserving water (3, 4, 6) . In her papers, each dog has a name or number, indicating the care she gave them. The first of these three papers (3) described in great detail the surgical preparation under anaesthesia of the dogs, and established the style of describing, analysing and discussing the measurements made that Mary used as a template for the subsequent studies over 25 years in which she used this whole animal model. Importantly, this paper also showed that the intestinal absorption of orally administered water was rapid, and was not a factor in the timescale of excretion of the water-load; furthermore, it showed that the renal innervation was not necessary for the diuresis, and the robust reproducibility of the phenomena was studied. This aseptic surgical preparation in the pre-antibiotic era was innovative and brave.
The second paper, in 1933 (4), established through key experiments a strong case for a key role of the posterior pituitary gland in driving retention of water by the kidney: first by showing that exercise-induced antidiuresis is not dependent on renal innervation; next by showing that a commercial posterior pituitary extract (sub-cutaneous Infundin, Burroughs Wellcome and Co.) induced antidiuresis, and that this action was unaffected by denervation of the kidney. The authors addressed, and rejected, possible objections to their inference that secretion by the posterior pituitary can account for antidiuresis by action on the kidney, and that diuresis with a water-load is a consequence of reduced posterior pituitary secretion, ablation of which causes a diuresis, as in diabetes insipidus. Crucially it was hypothesized that both increased and decreased posterior pituitary secretion is controlled by the brain. Thus, both papers (3, 4) refuted alternative contemporaneous explanations for the causes of variation in the output of water by the kidneys, an outcome that is still accepted.
In her later studies, Mary drew on Verney's experiments with this model, which he had used to show that 'osmoreceptors' in the distribution of the carotid arteries detected osmotic differences between the brain and the circulating blood (i.e. for injected hyperosmotic NaCl or sucrose, but not urea, which easily diffuses into the brain) to regulate ADH secretion (Verney 1947 ). This conclusion has been amply supported by later studies; indeed, the magnocellular oxytocin and vasopressin neurons themselves are osmoreceptors, as shown by electrophysiological studies (Bourque 2008; Leng & Russell 2019) .
Role of antidiuretic hormone (ADH; vasopressin).
Here we use 'ADH' for the uncharacterized active substance, as Mary did in her early work, and 'vasopressin' for the chemically characterized hormone. Earlier studies of neurohypophysial hormones had used commercially available extracts of the pars nervosa such as Pitressin and Pitocin (from Messrs Parke, Davis & Co.). However, starting in the late 1950s Mary's laboratory had access to synthetic or highly purified vasopressin (gifted by Vincent du Vigneaud and H. B. van Dyke) and synthetic oxytocin (Syntocinon; provided by Sandoz) for studies on the actions of the pure hormones. The Nobel Prize in Chemistry was awarded to du Vigneaud in 1955 for his work on sulfur-containing compounds of biochemical importance, including insulin, oxytocin and vasopressin (du Vigneaud 1955); his structural analysis and synthesis of vasopressin and oxytocin were crucial to the further development of the physiology of these hormones. Vasopressin and oxytocin were both shown to be nonapeptides containing a disulfide bridge and only differed in composition by two amino acids.
Mary's experiments were primarily on conscious dogs (mainly females), gently trained to accept experimental procedures to allow study of effects of manipulating the hypothalamoposterior pituitary system on the excretion of a water-load. Mary's work on dogs was not without difficulties, but these were always frankly described in detail in her papers and rigorous attempts were made to understand the causes of variability in results. Such variability in responses, small numbers of dogs and practice at the time precluded routine formal statistical analysis of data as is now expected, and Mary typically presented data for individual dogs as representing the cohort, and described in detail the different individual responses by the dog's name or number. For example, the variable reduced diuretic responses to a water-load after anterior pituitary removal was not explained, contrasting with the consistent polyuria after posterior pituitary removal or section of the neural stalk, which was readily attributable to lack of endogenous ADH (9) . Mary, together with John Watt (12), studied patients with pituitary tumours, before or after surgery, measuring renal clearances and ability to excrete a water-load. They found several patients that could not respond to a water-load with a diuresis, and some verged on water intoxication.
It is noteworthy that it is now recognized that marathon runners who die during a race have frequently drunk excessive amounts of water and, with inappropriate ADH (vasopressin) secretion owing to the exercise, have retained so much water that they are hyponatraemic with consequent fatal cerebral oedema (Siegel et al. 2007 ).
Control of vasopressin secretion by synaptic neurotransmitters: role of acetylcholine
Mary published a critical review of the field in 1945 (8), in which she set out her views on issues to be addressed, in particular focusing on the regulation of the neurons projecting to the posterior pituitary that secrete ADH or oxytocin. Typically, in this review Mary marshalled evidence to criticize and often refute various views of several other authors on how the hypothalamo-posterior pituitary system operates. Mary was hard on neuroanatomists, commenting that 'the mass of anatomical evidence is useless unless experiment and observation show that these pathways are used, and in what direction'; her concept was that the 'hypothalamic-hypophyseal tract is efferent', and that the stimuli controlling it, with respect to water balance, 'are central and not peripheral' (8). These conclusions were driven by the series of experiments Mary had started in Cambridge, as a Beit Fellow, to understand the chemical nature of synapses controlling the ADH and oxytocin neurons (7) (see below).
Mary published a further review in 1952 (18), which included a critical overview of bioassay of antidiuretic 'substances' (which might have included a helpful definition of a 'milliunit', mU, of ADH). Some negated concepts about ADH were listed, and evidence for lack of actions of ADH on glomerular filtration rate (GFR) or renal plasma flow (RPF) was summarized, confidently leaving action on tubules as the mechanism. Having noted the association of the length of the loop of Henle with urine concentrating ability among species, Mary focused on the distal tubule and collecting ducts, mentioning osmotic gradients but not yet the counter-current mechanism, decisive evidence for which was not provided until 1958 (Gottschalk & Mylle 1958; Wirz 1961) . Effective ADH concentrations were also detailed in the review (18). The issue of separate release of oxytocin and ADH and the central nervous system (CNS) mechanisms involved were discussed, considering evidence for acetylcholine and issues around sites of adrenalin action; however, renin and some other endogenous substances were given short shrift. Mary concluded that ADH is the only 'tissue substance' with the normal function of controlling water excretion per se. This remains valid 66 years later.
Acetylcholine. Mary had shown that intravenous (IV) acetylcholine given to dogs that had also received atropine (a parasympathetic muscarinic blocker) inhibited diuresis after a water-load, even with the kidneys denervated, and that this was not due to adrenalin but was prevented by ablation of the posterior pituitary. She deduced that acetylcholine acted centrally to excite the secretion of ADH: 'the effect of acetylcholine on the excretion of urine is due to an action in the central nervous system causing a liberation into the circulation of the antidiuretic hormone of the posterior pituitary body' (7) (here Mary recorded her thanks to Verney for his 'ever ready interest and advice'). Mary and John Watt further showed that acetylcholine injected via a carotid artery is much more effective than an IV injection (16). To critically test a central action, Mary exposed the ventral surface of the optic chiasm and pituitary gland in water-loaded anaesthetized dogs and bitches, and micro-injected acetylcholine directly into one supraoptic nucleus: this caused antidiuresis, indicating stimulation of ADH secretion (10). Co-injection of eserine (cholinesterase inhibitor, thus enhancing acetylcholine action-the principle of later twentieth-century neurotoxins developed for chemical warfare) prolonged the effect of acetylcholine, and injected alone into the supraoptic nucleus eserine caused antidiuresis, indicating tonic endogenous acetylcholine action. As further evidence for stimulation of ADH secretion, removal of the posterior pituitary prevented the antidiuretic response to acetylcholine injection into the supraoptic nucleus (10). This landmark 1947 paper clearly showed, for the first time, a role for acetylcholine neurotransmission in the brain and in a defined neuroendocrine system; Mary put it more modestly: 'The results described are not inconsistent with the hypothesis that acetylcholine stimulates the supraoptic cells' (figure 2).
Mary pursued this focus in a further series of studies. The acute and sustained effects of injecting diisopropylfluorophosphate (DFP), a longer-lasting cholinesterase inhibitor than eserine, into the supraoptic nucleus on urine flow showed rapid and prolonged inhibition of diuresis in anaesthetized water-loaded dogs, further indicating a role for acetylcholine in exciting vasopressin neurons (11) . Once recovered from the acute experiments, in the following days dogs that had been given DFP into the supraoptic nucleus showed polyuria, with an accompanying greatly increased water intake. The polyuria was suggested to be a result of 'a paralysing concentration of acetylcholine' due to sustained effects of DFP; histological study of the supraoptic nucleus showed some loss of supraoptic and paraventricular nucleus neurons (11) .
Subsequent studies have shown that there are cholinergic interneurons in the zone adjacent to the supraoptic nuclei, into which they send processes (Wang et al. 2015) , and in vitro electrical stimulation here excites vasopressin neurons via nicotinic receptors (Hatton et al. 1983) , while oxytocin neurons are excited by intracerebroventricular injection of acetylcholine (Moos & Richard 1989) ; some of the effects may be via presynaptic actions on other types of input . Even now, it is not clear what the functional role of cholinergic influence on supraoptic neurons might be, so cholinergic actions have not been fitted into a model of vasopressin or oxytocin neuron function. This seems strange considering that Mary's observations on effects of acetylcholine in the supraoptic nucleus were the first for any transmitter in this system. Nonetheless, abundant studies have now shown that many types of monoamine and neuropeptide inputs to vasopressin and oxytocin neurons are involved in the regulation of their secretory activity.
Actions of an opiate: morphine. Morphine was known to have antidiuretic actions, dependent on a functioning posterior pituitary, so, to address whether this opiate acted by stimulating ADH neurons, Mary, together with Helen Duke and John Watt (13), micro-injected morphine solution into the supraoptic nucleus in anaesthetized water-loaded dogs. Doserelated inhibition of diuresis was found, without change in blood pressure or consistent change in GFR or renal blood flow. Similar effects were seen with IV morphine in conscious dogs, which were prevented by surgical section of the supraoptico-neurohypophysial tracts, but did not involve functioning cholinergic mechanisms in the supraoptic nucleus.
Later studies of others (Tsushima et al. 1987 (Tsushima et al. , 1990 showed morphine or opioid peptides or fentanyl (a potent mu-opioid agonist) injected into the supraoptic nuclei in ethanolanaesthetized water-loaded rats, like Mary's findings in dogs, inhibited diuresis and increased urine osmolarity; these authors implicated a cholinergic mechanism. ADH secretion was not directly measured, but IV injection of ADH simulated the effect of morphine. However, there is a conundrum: later study in normally-hydrated dogs has found decreased urine flow after morphine, but without change in circulating vasopressin levels (Robertson et al. 2001) . Subsequent electrophysiological studies with morphine or a selective mu-opioid receptor agonist have consistently reported only inhibitory actions of these (and other opioids) on vasopressin neurons, all reversible by selective antagonists (Doi et al. 2001) . It may be that the water-loading in Mary's experiments introduced another factor that was morphinesensitive: water-loading would inhibit vasopressin neurons , so perhaps morphine could just reverse active inhibition. No doubt Mary would have enjoyed addressing the conundrum.
Role of adrenalin. In another experiment with Helen Duke, a cholinergic mechanism was sought in conscious dogs by which adrenalin could inhibit the stimulation of ADH secretion by an emotional stimulus. The study was presumed to test central interaction of these two transmitters on ADH secretion. Essentially, the results varied among dogs, and within dogs at different times, giving all possible outcomes (inhibition or enhancement of acetylcholine action, or no adrenalin effect) (15). Reasons for this were not established, but the suggestion in the paper that adrenalin interacts with acetylcholine 'possibly at the supraoptic nuclei' has to be considered a speculation rather than a conclusion from the study; IV adrenalin injection alone was shown to cause a brief antidiuresis (17). Nonetheless, subsequently, interaction between adrenalin and acetylcholine was clarified in experiments in which the transmitters were injected via a carotid artery. Diuresis induced by water-loading was inhibited by intracarotid acetylcholine injection (simulating an injection of ADH), and a low dose of adrenalin consistently blocked this effect, provided that adrenalin was injected in a time-frame of 8 to 45 s before acetylcholine. It was reasonably concluded that adrenalin blocked stimulation of ADH secretion by acetylcholine through a central action, though it was suggested this might have been because adrenalin transiently reduced blood flow in the supraoptic nucleus (21) .
Oxytocin: studies to test separate release from vasopressin Geoffrey Wingfield Harris (FRS 1953) had found that electrical stimulation of the neurohypophysis in conscious rabbits increased uterine activity and inhibited diuresis (Harris 1947) , and Barry Albert Cross (FRS 1975) reported that suckling in lactating rabbits caused antidiuresis (Cross 1951) . The issue of whether secretion of oxytocin and ADH could be released separately was addressed by Mary with Vince (Vivian) Abrahams in 1956 (21), using bitches given stilboestrol to sensitize the uterus to oxytocin. Spontaneous uterine contractions and urine flow were measured in water-loaded conscious animals. Hypertonic saline boluses given via a carotid artery (hence, the hypertonic stimulus would act centrally), but not by IV injection, inhibited urine flow and stimulated uterine contractions, with a similar time course. Prior section of the supraoptico-hypophysial tracts abolished the antidiuretic and oxytocic responses to intracarotid hypertonic saline, and to acetylcholine. Furthermore, in anaesthetized bitches treated with stilboestrol, injection of DFP or eserine into a supraoptic nucleus stimulated uterine contractions, indicating cholinergic excitation of oxytocin as well as ADH secretion (22). The antidiuretic and uterotonic actions of intra-arterial hypertonic saline could be replicated by IV injection respectively of Pitressin or Pitocin (posterior pituitary extracts with respectively antidiuretic and oxytocic activities), but it was estimated that 15-20 times more oxytocin than ADH was secreted in response to the different stimuli (20) . This estimate agreed with contemporary studies in other species cited in the paper (Harris 1947; Cross 1951) . As discussed in the paper, the interpretation of this difference can be related to different functions of ADH and oxytocin, with sustained low levels of ADH needed and sufficient to regulate water reabsorption or vascular tone, and more oxytocin needed to stimulate uterine contractions-we now know a pulsatile pattern of secretion of oxytocin, briefly reaching high circulating levels, is effective and efficient for its reproductive functions.
In a further study on the same dog model with Sheila Baird (a Muirhead Research Scholar), the hypothesis that stimuli that release oxytocin also release vasopressin was tested (29). Mary now had access to highly purified natural vasopressin as well as synthetic oxytocin (Syntocinon) and confirmed previous findings of selective actions, respectively, on kidney and uterus (20, 28) . In these studies, Mary used IV hypertonic sucrose solution during diuresis induced by a water-load as a stimulus to vasopressin secretion (after Verney 1947) . This caused antidiuresis, increased Na + excretion and stimulated uterine contractions; however, given separately, IV vasopressin had the first two effects, without stimulating the uterus, and oxytocin stimulated only uterine contractions. Without induced diuresis, IV hypertonic sucrose had the effects seen with diuresis, while oxytocin now increased Na + excretion as well as uterine contractions. None of these effects was seen after sucrose infusion in dogs with diabetes insipidus as a result of surgical removal of the posterior pituitary (28). This study clearly showed different actions of vasopressin and oxytocin, but did not separate their secretion in response to the hypertonic sucrose challenge.
Since these studies, hyperosmotic stimulation has been shown by specific radioimmunoassays and electrophysiological recording (neither available in Mary's working lifetime) to strongly stimulate both vasopressin and oxytocin neurons (Leng & Russell 2019) . By contrast, oxytocin neurons and secretion are selectively stimulated by suckling in lactation. It is now understood this separation is possible as oxytocin and vasopressin are produced almost exclusively in separate neurons, which can be stimulated or inhibited separately or together according to the neural pathways relaying the stimuli (Leng & Russell 2019) .
Oxytocin release and milk ejection during suckling
Mary used her water-loaded dog model to address further the question of whether ADH and oxytocin could be released separately in any physiological circumstance. For this she used lactating dogs, determining the amount of milk transferred to suckled puppies by measuring their weight gain, and then comparing this with the amount of oxytocin injected IV (Pitocin or Syntocinon) needed to let down this amount of milk-a method of auto-bioassay. She obtained an estimate of 10-20 mU oxytocin per milk ejection (33), which, after adjusting for body weight, compares well with later estimates in laboratory rats of 0.5 mU oxytocin per milk ejection. She also confirmed inhibition by adrenalin of the mammary gland response to oxytocin. Mary used a water-load to induce diuresis in lactating dogs to see if suckling induced antidiuresis, which it did, and without natriuresis (33). In Mary's study, stimulation by intracarotid injection of acetylcholine or hypertonic saline of antidiuresis and milk ejection led to the conclusion that both ADH and oxytocin had been secreted in response to suckling; however, later electrophysiological studies in rats showed that during suckling there is selective synchronous brief activation of oxytocin neurons without activation of phasically active vasopressin (ADH) neurons (Lincoln & Wakerley 1975; Poulain et al. 1977) .
Uterine contractions: oxytocin-sympathetic interactions
With Ricardo Deis (a post-doctoral fellow from Argentina) and in line with her research on interactions among neurohypophysial hormones, sex steroids and the sympathetic nervous system on blood vessels (see 'Re-orientation of Mary's research' below), Mary now used laboratory rats (and some guinea pigs) to study this issue on in situ uterine contractions (41). The expectation from the vascular studies (see below) was that high-oestrogen states would alter contractile uterine responses to oxytocin owing to altered sympathetic activity, although of course oxytocin never has relaxing actions on the uterus, unlike its fickle actions on blood vessels (35). Overall, surgical or pharmacological interruption of sympathetic activity enhanced spontaneous uterine contractile activity in low-oestrogen states, and only enhanced responses to IV oxytocin in such states; for example, in early but not late pregnancy there was clear evidence of increased activity after sympathetic blockade (41). The changes in reactivity during dioestrus could be attributed to restraint by alpha-receptor action, but betareceptor blockade with propranolol reduced the size of the contractions. These effects of autonomic blockade were reversed following treatment with progesterone, or progesterone and stilboestrol, and in these conditions the combined effect of alpha and beta blockade differed from the response to ganglionic blockade, which was not explained (51); this paper, her last presentation to the Pharmacological Society, on 13-15 September 1978, reported Mary's research from the University of Nottingham and the University of Brisbane. It was later realized that oestrogen and progesterone may act on different aspects of uterine betaadrenoceptor function (Nimmo et al. 1995) . We now know also that in late pregnancy the uterus is prepared by massive increase in oxytocin receptor expression to respond strongly to oxytocin.
In a conceptually inverted experiment with Vince Abrahams, she sought to test whether distension of the uterus might reflexly alter renal blood flow and function (27); the stimulus for this experiment was a suggestion that such a connection might underlie pre-eclampsia in pregnancy. Water-induced diuresis was not affected by uterine distension, so the hypothesis was negated. However, the study was not in pregnant dogs, and in late pregnancy reflex stimulation by uterine cervix distension would be expected to stimulate oxytocin secretion (Ferguson 1941) .
5-Hydroxytryptamine (5-HT; serotonin): antidiuretic action on the kidney
An action of peripheral 5-HT in producing antidiuresis, involving reduced GFR, had been reported by Erspamer (1954) , so Mary, with Abrahams, used the dog model of water-induced diuresis to study this further. Essentially 5-HT given by various routes had variable antidiuretic effects on urine flow and any effect was accompanied by reduced GFR and briefly reduced RPF, but did not require the posterior pituitary (23). Hence 5-HT did not act like ADH (which increases permeability of the collecting ducts to water), but reduced urine flow owing to vasoconstriction and reduced GFR while increasing blood pressure. Thus, Mary rejected the idea that 5-HT is a renal hormone. Also unlike ADH, IV 5-HT constricted the ureter in situ, sufficiently to block urine flow for a few minutes (24). Actions of IV 5-HT were also tested on the uterus in anaesthetized and conscious, non-pregnant and ovariectomized dogs; a uniform response of a contraction followed by inhibition was seen, at lower doses than needed for effects on diuresis or the ureter (25). Together, these findings at least showed that the kidney was not especially sensitive to actions of 5-HT (23).
Natriuretic actions of oxytocin-depending on species
Mary was interested in the mechanisms of the fluid retention associated with actions of oestrogens. One approach was to evaluate actions on renal function, and in particular on actions of posterior pituitary hormones. In normal bitches with water-induced diuresis there is a continual decrease in electrolyte excretion (26). Mary proposed that oxytocin might have important effects on renal function, and tested actions in the water-loaded conscious female dog model during diuresis (28). In this study Mary was now able to use IV synthetic peptides as well as commercial posterior pituitary extracts. Vasopressin inhibited diuresis and modestly increased or had no effect on electrolyte excretion; oxytocin (ca 30-fold greater amount than vasopressin to match estimated secretion ratio) had an antidiuretic action, but a marked natriuretic action only at low urine flow rates, i.e. when vasopressin would be present instead of suppressed by the oral water-load (figure 3). Given instead by intracarotid injection (tested on only one dog), oxytocin had a large natriuretic effect in basal conditions. A 'central' action of oxytocin was inferred, although the site of such action was not shown.
Françoise Moos and Philippe Richard (Moos & Richard 1989) subsequently found that oxytocin released by the dendrites of oxytocin neurons themselves has essential autoexcitatory actions that co-ordinate burst-firing and cause secretion of pulses of oxytocin for milk ejection (Rossoni et al. 2008) . Whether oxytocin can enter the brain from the circulation is a highly controversial contemporary issue; there is substantial evidence that it cannot Oestrogen effects on renal actions of oxytocin and vasopressin. Using the conscious water-loaded diuretic bitch model, a marked delay and reduction in water and electrolytes excreted was found a day after stilboestrol treatment. Furthermore, an oral saline load was not adequately excreted, owing to reduced diuresis; stilboestrol increased GFR and especially RPF (32). Notably, in this study on 13 dogs, before stilboestrol treatment the variability in water excretion during diuresis was small, just 8%. In three bitches with diabetes insipidus (induced by previous surgical section of the supraoptico-hypophysial tracts or posterior pituitary removal) stilboestrol increased Na + excretion. Hence, stilboestrol treatment reduced ability to excrete water and Na + when challenged with a water or salt load, which reduction seemed to need the posterior pituitary gland.
Changes in responses to ADH and oxytocin were sought in a further study with Ricardo Deis. Normal anoestrous bitches were tested before and 1-2 days after stilboestrol treatment for Pitressin (ADH) effects on water-induced diuresis and electrolyte excretion (Na + and Cl − ); no effect of stilboestrol was found on the antidiuretic response to Pitressin, but the natriuretic effect was reversibly inhibited. Similarly, the stilboestrol pre-treatment inhibited the natriuretic response to IV oxytocin, but not if oxytocin was given into a carotid artery. However, in a single dog studied without induced diuresis, i.e. with a low urine flow rate, IV stilboestrol increased natriuresis induced by IV oxytocin; progesterone treatment alone or with stilboestrol had no effects (37). In the absence of information about mechanisms of oestrogen action on the kidney, Deis and Mary (37) proposed that stilboestrol might act to alter vasoconstrictor actions of vasopressin and oxytocin in the kidney, or cause retention of water and electrolytes in the body overall by actions on tissues. The former possibility is a thought in line with Mary's laboratory's work on peripheral blood vessels.
Human studies on possible natriuretic actions of oxytocin
While natriuretic actions of oxytocin have been described in several species, Mary's collaborative study to test effects in men and women (20 and 15 recumbent participants respectively) showed in almost all participants a lack of natriuretic responses to IV infusion of oxytocin after water or salt loading, and no effects on GFR or renal blood flow (34). These negative results contrast with data from study of cardiovascular effects of oxytocin. Oxytocin, or an analogue, infused via a vein or brachial artery was shown with plethysmography in 10 participants to cause vasodilatation in the infused arm and hand, with an increase in heart rate and a small decrease in blood pressure (30) ; hence, humans did have a peripheral vascular response to oxytocin similar to that seen in dogs.
Subsequent research has confirmed the natriuretic action of oxytocin in water-loaded dogs (Andersen et al. 1992 ) and rats (Balment et al. 1986; Verbalis et al. 1991) . However, production of oxytocin in the heart and actions in the heart, in particular through stimulation of the release of atrial natriuretic peptide (ANP; characterized in 1983), evidently comprise an important mechanism (Gutkowska et al. 2000) This is now considered to be the way in which oxytocin increases sodium excretion (but not in man; Rasmussen et al. 2004) , rather than via direct actions on the kidney or centrally. Nonetheless, stimulation by IV hypertonic saline of both oxytocin and vasopressin neurons and oxytocin and vasopressin secretion from the posterior pituitary gland has been repeatedly and unequivocally demonstrated, with vasopressin certainly acting on the kidney to conserve water, and oxytocin likely acting on the heart to stimulate ANP secretion to act on the kidney to increase NaCl excretion.
Adrenal medulla control over adrenal cortex: a possible mechanism in stress responses
In 1950 both Marthe Vogt (FRS 1952) and Mary were based in Edinburgh, so they could combine expertise and collaborate. The question they addressed was whether IV adrenalin, a fast response stress hormone from the adrenal medulla, stimulated hormone release from the adrenal cortex via a direct action or by stimulating adrenocorticotropic hormone (ACTH; corticotropin) secretion from the anterior pituitary gland (14). Dogs were surgically hypophysectomized and the median eminence destroyed several days before the experiment under anaesthesia with blood samples collected from an adrenal vein, for bioassay of adrenal corticoid hormone (using survival time of adrenalectomized rats exposed to cold as the endpoint). Several factors, especially incomplete hypophysectomy, complicated this experiment, though there was an indication that adrenalin may act via the anterior pituitary. At this point, in 1952, Mary was a discussant in a CIBA Symposium on Anterior Pituitary Hormones and Hormonal Influences in Water Metabolism (19) .
Much later, adrenalin was shown to stimulate corticosterone secretion in hypophysectomized rats (Inaba & Kamata 1975) and Walker et al. (1988) showed that in vitro adrenalin stimulates cortisol secretion from adrenocortical cells. It was also shown that IV adrenalin increased ACTH secretion in conscious (Proulx-Ferland et al. 1982 ) and anaesthetized rats (Tilders et al. 1982) , and that adrenalin stimulates corticotrophs in vitro (Labrie et al. 1984) . With advanced techniques that were not available in 1951, adrenalin has been revealed to act on both the anterior pituitary and the adrenal cortex to increase corticoid secretion; evidently, the uncertain conclusion about site of action in the 1951 paper (14) was correct.
Re-orientation of Mary's research
In the mid 1950s, Mary began to address questions about the interactions between female sex steroids and oxytocin actions, from the standpoint that reproductive actions of oxytocin are important at times when levels of these steroids are high (as at ovulation and in pregnancy), or decreasing (after pregnancy), and may be important in disturbances around the menopause. In particular, Mary investigated actions of oxytocin on uterine contractions (see Uterine contractions: oxytocin-sympathetic interactions, above) and then focused on the tone of smooth muscle of the vasculature. The latter focus had potential for understanding the mechanism of menopausal 'hot flashes' or 'hot flushes', and became the basis for Mary's research until she retired. In the course of these experiments she included collaborative studies on human subjects (men and women).
Vascular actions of oxytocin
Vascular relaxing actions of oxytocin and reversal of effects by oestrogen in females
Sybil Lloyd was an MSc student in Mary's laboratory in the late 1950s. It was Mary's practice around this time to encourage young scientists and medical students to work with her and publish single author papers; these papers all acknowledged her support, and are included here because Mary later followed up their observations in detail in subsequent papers. Sybil's work (Lloyd 1959a (Lloyd , 1959b on the vascular actions of pure vasopressin and synthetic oxytocin was performed on rats, and many of the observations were later confirmed in other species, including humans, in collaboration with Mary. This work identified differences in the actions of these peptides on the vascular system and also found that their actions were modulated by the presence of oestrogens. In particular the normal vascular response to oxytocin was a fall in arterial pressure, but in the presence of oestrogen, and during late pregnancy, oxytocin increased arterial pressure. Later it was shown that sympathetic denervation could also cause oxytocin to become a vasoconstrictor (36) (figure 4).
The factors that convert the vascular response to oxytocin from normal vasodilatation to vasoconstriction, and those that reinstate the vasodilator effect, occupied much of the rest of Mary's research life. Nowadays we recognize the roles of vascular smooth muscle, autonomic nerves and endothelium in the resistance vessels, but Mary's work was done two decades before the realization of the active role played by the endothelium. Nevertheless, her work points to a dynamic system influenced by steroid hormones and autonomic nerve activity that specifically affect the vascular response to oxytocin. By acting on the single oxytocin receptor, oxytocin could induce two contrasting actions: vasodilatation or vasoconstriction. That was the puzzle.
Relevance to vascular disturbances in women. Cardiovascular changes in pregnancy, such as hypertension, pre-eclampsia and eclampsia, were largely unexplained and the finding that oestrogen altered vascular reactivity was of obvious importance. In addition, variations in oestrogen levels seemed to be the basis of flushing (syn. flashing) during the menopause, and might be related to the alteration of vascular reactivity to oxytocin with changing oestrogen levels that Mary had observed. Another vascular condition, Raynaud's syndrome, also occurs more frequently in women. The conversion of the depressor action of oxytocin into a pressor one in the presence of oestrogen seemed to provide a handle with which she could study the basic physiology underlying some of these conditions.
Vascular interactions between oestrogens, oxytocin and vasopressin: switching between
vasodilator and vasoconstrictor actions of oxytocin Lloyd (1959b) made the fundamental observation that in normal male rats and in female rats during dioestrus (when oestrogen levels are low) oxytocin caused peripheral vasodilatation and lowered arterial blood pressure. However, during oestrus (when oestrogen levels are high) the peptide caused an increase in arterial pressure. The pressor action of vasopressin was also enhanced during oestrus. The normal vasodilator activity of oxytocin converted to vasoconstriction during the second half of pregnancy in the rat (when both progesterone and oestrogen levels are increased), and oxytocin increased arterial pressure at this time (Lloyd 1959a) . The pressor action of oxytocin continued into the first two days of the post-partum period. In addition, vasopressin had a greater pressor effect in the later stages of pregnancy. The vascular actions of other endogenous vasodilators were unchanged during pregnancy, during the oestrous cycle or following the administration of oestrogen (Lloyd 1959a) (35) .
Further work in rats and dogs confirmed the effects of oestrogen in modulating the vascular response to oxytocin; it was shown that oxytocin normally increased blood flow to a hindlimb, but decreased it after the administration of oestrogen (36). In humans it was found that intraarterial administration of oxytocin caused vasodilatation in the injected limb (40) and that intravenous oxytocin caused an increase in cardiac output (30) ; valyl 3 -oxytocin, an analogue of oxytocin, was found to have similar vascular effects to oxytocin (Syntocinon) in humans (31) . Oestriol injection into the arterial supply to one hand caused the response to oxytocin to be converted from vasodilatation to vasoconstriction, but only in that hand; the response to oxytocin in the contralateral hand continued to be vasodilatation (40). These experiments indicated that the action of oestrogen was local, on the limb blood vessels.
Other sex steroids: males and effects of testosterone on vascular responses to oxytocin and vasopressin
Medical students on summer research scholarships studied the effects of other steroid hormones on the vascular responses to oxytocin. Louis Honoré studied male rats and the effects of castration and testosterone administration on the vascular actions of oxytocin and vasopressin (Honoré & Lloyd 1961 : Honoré 1964 . The vascular responses to oxytocin and vasopressin were unchanged immediately after castration, but five or six days later, the pressor response to vasopressin was increased and prolonged, and oxytocin depressed arterial pressure, which changes largely returned to normal by the eleventh day, except for a prolonged pressor response to vasopressin. Administration of testosterone to male and female rats caused oxytocin to have a pressor action. Oxytocin also raised arterial pressure in progesteronetreated rats and during pseudopregnancy (Fullerton & Morrison 1965) ; however, this pressor response to oxytocin was unaffected by combining progesterone and oestrogen. Barraclough (1961) had shown that the oestrous cycle became disrupted if rats had been injected with testosterone on the fifth day of post-natal life. Female rats that had been given a single dose of testosterone and male rats that had been given a single dose of stilboestrol when five days old were studied at the age of 3-4 months; as expected, the females were in a persistent oestrus state. Oxytocin had a pressor effect in both sexes (39). These findings pointed to early life programming, as it would now be called, by sex steroid exposure of cardiovascular responses to oxytocin in adulthood.
Interactions between the sympathetic nervous system and vascular responses to oxytocin
In rats, the vascular response to oxytocin was found to depend on the integrity of the sympathetic nervous system; normally, oxytocin depressed arterial pressure, but raised it after surgical or pharmacological sympathectomy. Further studies required measurements of blood flow and more controlled manipulation of sympathetic activity, and for technical reasons it was necessary to use larger animals. The normal vasodilatation induced by oxytocin was reversed, i.e. became vasoconstriction, following sympathetic blockade or sympathetic denervation and this indicated that sympathetic nerves were essential for the normal responses to the peptide. This conclusion was based on studies in the early 1960s on rats (35) (Honoré & Lloyd 1961) , dogs and monkeys (39, 42, 43) and humans (30, 38, 40) . It was proposed that oxytocin acted directly to contract vascular smooth muscle, and that when oxytocin caused vasodilatation this was due to over-riding central activity in the sympathetic system (37).
Mary would often use pharmacological tools to examine physiological mechanisms and she was aware that some anticholinesterases, such as eserine (physostigmine), stimulated the sympathetic nervous system via a central mechanism, whereas others, such as prostigmine, did not (Varagic 1955) . Eserine reversed the pressor response to oxytocin of rats in natural oestrus or animals treated with an oestrogen (42, 43) (Fullerton & Morrison 1965) , whereas prostigmine did not. So, it seemed that a centrally mediated increase in sympathetic activity in oestrogen-primed rats could cause the action of oxytocin to revert to vasodilatation. By way of contrast, eserine did not eliminate the pressor response to oxytocin in progesterone-treated rats (Fullerton & Morrison 1965) ; hence, progesterone evidently did not interact with sympathetic control of blood pressure.
The idea that the vasodilatation produced by oxytocin was dependent on sympathetic nerve activity was examined in dogs and monkeys, in which it was possible to control sympathetic activity in one limb (42). Sympathetic denervation of one limb was accomplished by cutting the sympathetic chain on one side, and causing oxytocin to be a vasoconstrictor in that limb. Electrical stimulation of the peripheral cut end of the sympathetic chain supplying that limb restored a vasodilatation normally associated with oxytocin (42). This confirmed that the sympathetic nerves played a role in the vasodilatation induced by oxytocin. The identities of the amines that induced these reversals were examined further in experiments that showed that the vasodilator response to oxytocin was restored during adrenalin infusion, but, surprisingly, not during infusion of noradrenalin, the major sympathetic transmitter.
Interaction between oestrogen and sympathetic nerves
Electrical stimulation of the cut sympathetic trunk also reversed the oxytocin-induced vasoconstriction in oestrogen-primed animals. It was found that, following oestrogen administration, the normal vasodilator response to oxytocin was restored either during infusion of adrenalin or during sympathetic nerve stimulation provided in both cases that the muscarinic receptor antagonists atropine or hyoscine had been given previously. Also, in the absence of atropine or hyoscine, adrenalin and nerve stimulation were also ineffective in restoring the vasodilator action of oxytocin. In no circumstances did noradrenalin restore the normal response to oxytocin. J. H. Burn FRS and M. J. Rand (Burn & Rand 1960) had provided evidence for a peripheral store of adrenalin that could be released by stimulation of cholinergic sympathetic nerves, and which accounts for the effective use of muscarinic antagonists in this experiment.
Conclusions about modulation by oestrogen of vascular actions of oxytocin
In 1967 Mary published a paper with Sybil Lloyd that summarized their views on how the vascular response to oxytocin changed from vasodilatation to vasoconstriction following administration of oestrogen, sympathectomy or sympathetic blockade (43). They focused on the mechanisms underlying the vasodilatory action of oxytocin, and showed the importance of adrenalin released by sympathetic nerve activity. They also showed that the adrenal medulla (the major source of circulating adrenalin), the adrenal cortex or beta-adrenoceptors were not involved in the reversal of the action of oxytocin. In the case of oestrogen-primed animals, blockade of muscarinic mechanisms was also involved. An oxytocin analogue, tyrosinemethyl 2 oxytocin, which has a high receptor affinity but a low intrinsic activity, was found to block both pressor and depressor actions of oxytocin, and they concluded that a single oxytocin receptor was involved in both responses. It has been shown more recently that the oxytocin receptor is indeed encoded by a single gene located on chromosome 3p25 (Simmons et al. 1995) .
Chronic sympathectomy permanently impairs vascular responses to oxytocin
Attempts were made to see whether, following sympathectomy, nerve regeneration would restore the dilator response to oxytocin, but the results were negative, even allowing many months for the nerves to regenerate. While the normal vasoconstrictor response to sympathetic stimulation did return, the response to oxytocin did not return to normal even during adrenalin infusion. The conclusion in the late 1960s was that not all functions of sympathetic nerves return at the same rate during regeneration (43). Later, Mary retained the view that 'Whatever the change may be that induces a permanent abnormality (i.e. the inability to re-establish a vasodilator response to oxytocin), it depends on the absence of centrally originating sympathetic activity and seems to set in as soon as the central impulses cease' (49) . Other possible contributory factors are now recognized relating to the effects of chronic sympathectomy. Possibly 30% of post-ganglionic neurons do not regenerate following transection (Lisney 1989) , and the phenotype of the regenerated neurons is probably determined by the target organ with which the fibres reconnect (as in normal development). Furthermore, interestingly, arterioles can change their sensitivity to catecholamines following pre-ganglionic denervation or spinal injury (McLachlan 2007) , and such change may involve pre-and post-synaptic mechanisms within the wall of the blood vessel.
Hypertension: angiotensin II and sympathetic nerve activity
The importance of controlling arterial hypertension was being realized widely within the profession in the early 1960s, but little was known about the mechanisms of 'essential hypertension', and the possibility of a hormone acting centrally on sympathetic pathways was of general interest. Angiotensin II, a potent vasoconstrictor, had become available as a pure synthetic peptide and there was considerable interest in elucidating its many properties, and its potential role in essential hypertension. One hypothesis about angiotensin II was that it could increase sympathetic activity by a central mechanism (Bickerton & Buckley 1961; Smookler et al. 1966) , and the decision was made to record sympathetic activity directly by electrophysiological recordings from sympathetic nerves. John Morrison, working with Mary in the 1970s, studied the effects of intravenous angiotensin II and noradrenalin on single units in the cervical sympathetic nerves of anaesthetized cats and dogs (47). No quantitative difference was found between the actions of angiotensin and noradrenalin in lowering sympathetic efferent discharge during infusion of these compounds (47). In the studies of angiotensin and noradrenalin on sympathetic efferent discharge, Mary's instructions were to make a note of the sex of every animal used, and maybe it should not have come as a surprise that in male, but not female, animals sympathetic discharge could increase during severe hypertension induced by noradrenalin or angiotensin. This increase was shown to be due to vasoconstriction in the arterial chemoreceptors and the sensitivity of the carotid bodies to these chemicals in male animals could be attributed to the higher rate of metabolism in the chemoreceptors in the presence of testosterone. This reflex effect was dependent on intact arterial chemoreceptor afferent nerves (48). Much later it was recognized that the sensitivity of arterial chemoreceptors in cats and humans was greater in males owing to the presence of testosterone (White et al. 1983 (White et al. , 1985 .
The 1967 paper (43) had summarized Mary's views on how the vascular response to oxytocin changed from vasodilatation to vasoconstriction following administration of oestrogen, sympathectomy or sympathetic blockade. Mary's persistence in investigating the mechanisms underlying the vasodilator response to acute administration of oxytocin served as a fore-runner to the more recent view that chronic administration of oxytocin causes a lowering of arterial pressure (Petersson et al. 1996 (Petersson et al. , 1997 (Petersson et al. , 1999 , i.e. that the elusive vasodilator response has proved to dominate in chronic experiments.
Decades after Mary did her experiments, the role of the endothelium (Furchgott & Zawadzki 1980 ) and the involvement of endothelial nitric oxide in vasodilatation was understood in some detail (Moncada 1999) . Endothelial cells express oxytocin receptors (Thibonnier et al. 1999) , and oxytocin appears to produce vasodilatation by the release of nitric oxide (Thibonnier et al. 1999 ) and also ANP (Gutkowska et al. 2014) . Oestrogen can affect the sensitivity of vascular adrenergic mechanisms and vascular tone (Colucci et al. 1982) . It is thus not so surprising that the actions of oxytocin on a single receptor might change from vasodilatation to vasoconstriction depending on the mix of hormonal, autocrine and neural influences pertaining at the time, as Mary and Sybil had found in 1967 (43) .
An explanation for menopausal hot flushes/flashes?
There are clear indications in Mary's publications that her findings about the direction of actions of oxytocin on vascular tone being dependent on both oestrogen status and the sympathetic input would provide an explanation for the hot flushes/flashes that seriously trouble many menopausal women, and likely point to rational management. Indeed, oestrogen replacement is now well-established to effectively ameliorate this problem. However, it seems now that the flushes/flashes result from disturbed functioning of the body temperature regulating mechanism in the hypothalamus (Sturdee 2008) . Any role for oxytocin has not been clarified beyond Mary's original work. Instead of oxytocin, a role for another hypothalamic peptide, neurokinin-B (NKB), unknown in Mary's working lifetime, is indicated by the stimulation of flushing by IV NKB infusion in healthy pre-menopausal women (Jayasena et al. 2015) . Mary would have relished seeking to investigate the mechanisms.
Mary's other achievements and qualities
Mary was fascinated by the fact that some hormones act on the CNS. Her only book, The central role of hormones, was published in 1969 (45), and is remarkable because it is not mainly based on her research, but is her account and synthesis of knowledge and understanding, from the achievements of others, of the importance of actions of hormones on the brain, the secretion of hormones by the brain and control of hormone secretion by the brain; a huge challenge. This book was approachable by the relatively naive at the time, yet provides experimental evidence for her assertions. The book is full of information about a range of topics, including brain development, sexual differentiation, indications of the coming of molecular biology and electrophysiology to the field, and behaviours regulated by hormones. It was written before hypothalamic releasing factors had been characterized, just a few years after the female contraceptive pill was introduced (only the principles for this were alluded to in the context of feedback) and there was sparse information available about receptor molecules. There is little now to disagree with, though the comments about the nature of homosexuality belong in the 1960s.
Her experiments at this time led her to ask questions as to whether peptides such as oxytocin and angiotensin II might also act centrally through excitation of central autonomic pathways. The current controversy about whether oxytocin can enter the brain from the circulation has been mentioned above (Leng & Ludwig 2016) . By way of contrast it is well-established that there are regions where the dipsogenic and hypertensive peptide angiotensin II can cross into the brain where the blood-brain barrier is deficient, such as the subfornical organ (Tanaka et al. 1985) , and then act on neurons (Paton et al. 2008) . Several other peptides can enter the brain, circumventing the blood-brain barrier by different routes to act directly on neuronal networks subserving numerous functions (Russell 2018 ).
Mary's other qualities
Mary Pickford was a respected conscientious teacher and mentor; she would invite her tutorial groups to her home and entertain them with good food and stories about her travels, including telling about the fun she had riding elephants as a child in India. She was also supportive in other ways, especially of the welfare of female students. Anecdotally, as a member of the faculty committee that considered exclusion of students, in the case of a male student who had got two young women pregnant Mary advocated exclusion not on moral grounds but because he was ignorant of the basic facts about timing of fertility in a woman.
She could be very charming, had a great sense of humour and a very definite presence; she could also be quite forthright in her opinions. She once mentioned that a senior colleague had asked her about how to apply to become an FRS; she said, 'you don't, you wait to be asked'. On returning from four months in Australia in 1977, Mary had a letter published in the British Medical Journal (50) criticizing the implications in a review of the Biographical Memoirs of the Royal Society that Fellows lacked 'interest in the big wide world'; Mary's own story herein gives the lie to this.
Mary's involvement with continuing medical education included articles in postgraduate and hospital journals, leading articles in the Lancet, lectures to postgraduate students and sitting on the board of examiners at the Royal College of Surgeons of Edinburgh.
Mary maintained friendships with many of her collaborators and students. Vince Abrahams, Frank Brooks and John Morrison visited her and had return visits to their homes over many years. In the 1960s Mary had contracts with the NASA space programme, which funded her research (44). Visiting research managers had to be entertained and on occasions her research students were invited along to help entertain them and dine in some of the best restaurants in Edinburgh. There were also many famous scientists visiting the laboratory during that period, and one, Frank Brooks, from the University of Pennsylvania, later became an important influence in the career of John Morrison, a co-author of this article, as invitations to speak at international conferences in Philadelphia in 1976, and later in Germany, can be traced back to those early introductions.
Mary never married, and often visited her brother, Charles, and her two nieces in Chelsea during the summer. After her retirement in 1972, Mary took up residence in the Pickford family's Derbyshire home in Kingsterndale-the Hall, a large stone-built house in its own grounds and with a sizeable walled kitchen garden. Mary's cousin, Catherine Kirkland, who was an excellent violinist and whom she had known since childhood, lived with Mary in Kingsterndale until health issues caused her to move south. For a time, Mary worked part-time as special professor of endocrinology at the University of Nottingham, where she continued her research (33).
Mary's main relaxation before and after retirement included walking in the countryside, botany, art and music; during the war, she had encouraged people to sing, and she had sung Beethoven's Missa Solemnis as a member of the chorus. Her paintings and jewellery she had made were exhibited and sold before and after her retirement (before Mary left Edinburgh she sold two paintings to John Russell, co-author of this article), and she regularly exhibited during the Edinburgh Festival on the Scotsman steps. In 1981 she was delighted to win first prize (£150) for a watercolour and second prize (£100) for an oil painting entered into the Private Patients Plan Painting Competition.
The home in Kingsterndale was sold in 1982 and Mary returned to Edinburgh, to a large terraced house in Murrayfield. She occasionally dropped into the physiology department, arriving in her magnificent Rover saloon car, and gave her encouragement and shared her wisdom with former colleagues. Her smile and sense of humour never failed, and it was occasionally possible to return some of the hospitality she had shown to her students.
In 1996 she moved south to a nursing home in Hampshire to be closer to her niece, donating her books to John Russell before leaving. She still remained in contact with some of her former students by sending hand-written letters; by that stage in her life she bemoaned the fact that most of her friends and relatives, apart from her nieces, had died; nevertheless, she was determined to reach her own century-just! She died on the morning of her 100th birthday at Nether Wallop, Hampshire, on 14 August 2002 (as the Faculty of Medicine in Edinburgh was arranging to send her birthday wishes) and was buried at Kingsterndale.
When asked about experience relevant to becoming a Fellow of the Royal Society, Mary noted that she had had good colleagues, good health and good luck. In particular she mentioned Verney, W. H. Newton, and Marthe Vogt, whom she described as a mine of information and always willing to help. The importance of the debates in the Physiological Society, in keeping the subject alive, and the encouragement and kindness of her seniors were important during many moments of depression; in particular she mentioned A. V. Hill FRS, H. H. Dale FRS, T. R. Elliot FRS, Sir Walter Fletcher FRS and Sir Edward Mellanby FRS.
The Mary Pickford Lecture
In 2015, to honour Mary's scientific achievements, and recognize her as a pioneer in neuroendocrinology (Breathnach & Moynihan 2013) and as the first woman to be appointed to a medical chair at the University of Edinburgh, the Centre for Integrative Physiology at the College of Medicine and Veterinary Medicine of the University of Edinburgh established the Mary Pickford Lecture. Each year an outstanding female scientist in a field related to Mary's interests is invited to give this lecture. See: https://www.ed.ac.uk/biomedical-sciences/athenaswan/women-in-science.
Honours and fellowships
In 1954 Mary was elected a Fellow of the Royal Society of Edinburgh. She was a member of the Society for Endocrinology, the Renal Association and the New York Academy of Sciences. In 1966 she was the first woman made a medical professor (of physiology), and the first appointed to a personal chair in the University of Edinburgh. She was elected Fellow of the Royal Society of London in the same year, and two years later was elected Fellow of University College London; she was an honorary member of the Physiological Society, the Pharmacological Society and the Society for Endocrinology. On retirement in 1972 she was made emeritus professor; in 1991 she was given an honorary DSc by Heriot-Watt University, Edinburgh; and she became a Fellow of the Royal College of Physicians of Edinburgh in 1997.
Author profiles
John F. B. Morrison
John Morrison graduated BSc (Hons Physiology) and MBChB from the University of Edinburgh Medical School, where he then completed a PhD under the supervision of Mary Pickford. He was appointed to a lectureship in the Department of Physiology at the University of Leeds in 1970, where he stayed (eventually as head of the Department of Physiology) until 1998. After retirement he took on a position as professor and chair of the Department of Physiology, Faculty of Medicine and Health Sciences, United Arab Emirates University. Much of John's work has been on the scientific basis of neuro-urology, and more recently on the pathophysiology of diabetic sensory and autonomic neuropathies. He has edited two books and published over 110 peer-reviewed scientific papers and reviews. He is a member of the Physiological Society, the British Neuroscience Association and the International Continence Society; and member and/or chair of the scientific committee of the International Consultations on Incontinence (1998) (1999) (2000) (2001) (2002) (2003) (2004) (2005) (2006) (2007) (2008) . He was the recipient of the Mahalanobis Gold Medal of the Indian Physiological Society.
John A. Russell John Russell studied medicine at the University of Edinburgh Medical School, graduating BSc (Hons Physiology) and MBChB, and then completed a PhD in neuroendocrinology. He was appointed lecturer in the Department of Physiology at the University of Edinburgh, where he has spent the rest of his career, including serving as head of department and head of biomedical sciences, and is now emeritus professor of neuroendocrinology. His research has focused on adaptations in neuroendocrine mechanisms in pregnancy and prenatal stress impact on offspring; he has published more than 200 research papers and reviews. He has served as chairman of the British Society for Neuroendocrinology (BSN) and president of the International Neuroendocrine Federation. He is an honorary (senior) member of the Physiological Society, the Society for Endocrinology, BSN and the Polish Society for Neuroendocrinology. He has been a scientific editor for the Journal of Endocrinology, deputy editor in chief for the Journal of Neuroendocrinology and editor in chief of Stress -the International Journal on the Biology of Stress. He has contributed to and edited several books in neuroendocrinology/physiology. He was a recipient of the Ewy Medal, Agricultural University, Krakow.
